Department of Cardiovascular Surgery, Federal University of São Paulo, São Paulo, Brazil.
Eur J Cardiothorac Surg. 2012 Mar;41(3):696-8. doi: 10.1093/ejcts/ezr038.
Tricuspid valve disease is not uncommon. Some patients with tricuspid valve disease require tricuspid replacement with bioprosthesis and, over time, may require re-interventions. Transcatheter tricuspid valve-in-valve approach has emerged as an alternative to treat dysfunctional bioprosthesis. In this article, we report a case of a patient with four previous cardiac interventions presenting with tricuspid bioprosthesis dysfunction. The patient was treated with the transcatheter transatrial tricuspid valve-in-valve procedure. The procedure was successful with no residual leakage and a non-significant mean gradient. The patient recovered well and was discharged in 1 week. The procedure is a feasible alternative for high-risk patients. Selection and postoperative care are crucial for the outcome.
三尖瓣疾病并不少见。一些三尖瓣疾病患者需要使用生物假体进行三尖瓣置换，随着时间的推移，可能需要再次介入治疗。经导管三尖瓣瓣中瓣技术已经成为治疗生物瓣功能障碍的一种替代方法。本文报告了一例曾接受过 4 次心脏介入治疗的患者，该患者出现三尖瓣生物瓣功能障碍。该患者接受了经导管经房间隔三尖瓣瓣中瓣治疗。该手术过程成功，无残余漏，平均跨瓣压差无显著变化。患者恢复良好，1 周后出院。该手术是高危患者的一种可行的替代方法。选择和术后护理对手术结果至关重要。
